See your results below for :
Arexvy 120MCG/0.5ML
:
Suspension Reconstituted - 1
Arexvy Coupons & Prices
What is Arexvy ?
Arexvy, also known as the RSVpreF vaccine, is a bivalent vaccine developed by GSK for the prevention of respiratory syncytial virus (RSV) infections in older adults. Approved by the FDA in 2023, it is specifically designed to target and neutralize two key subtypes of the RSV virus, offering enhanced protective efficacy. This vaccine is administered as a single dose and is recommended for individuals aged 60 and older to reduce the risk of severe RSV-associated respiratory illness.
Arexvy
Consumer Forms
Consumer Routes
Therapeutic Classes
- Nausea
- Headache
- Dizziness
- Fatigue
- Do not use if you have severe liver impairment.
- May cause drowsiness, do not drive or operate heavy machinery until you know how Arexvy affects you.